AZD 6244

epidermal growth factor receptor ; Mus musculus







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34856074 Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors for cancer treatment. 2022 Mar 1
2 32888253 Proteomics identifies EGF-like domain multiple 7 as a potential therapeutic target for epidermal growth factor receptor-positive glioma. 2020 Oct 4
3 22144664 MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model. 2012 Feb 1